TP53 and Miyoshi myopathy: This is expected considering the relative absence of patterns of genomic instability and the early driver role of chromothripsis in MM, while the acquisition of other known features responsible for genomic complexity such as TP53-inactivation and APOBEC- mutational activity occur later26,39.